Market Currents
Forest Labs (FRX +3.5%) gains on an upgrade to Outperform at Leerink, citing the blockbuster...
-
Thursday, May 31, 2012, 2:50 PM ETForest Labs (FRX +3.5%) gains on an upgrade to Outperform at Leerink, citing the blockbuster potential of the company's aclidinium franchise, sales growth expectations from new product launches and its attractive potential as a takeover candidate. The firm also raises its price target to $41 from $33 - $34.
Other date
HEALTHCARE ETFs IN FOCUS
Latest Healthcare Articles
